Logo image of BTSG

BRIGHTSPRING HEALTH SERVICES (BTSG) Stock Fundamental Analysis

NASDAQ:BTSG - Nasdaq - US10950A1060 - Common Stock - Currency: USD

21.32  +0.14 (+0.66%)

After market: 21.32 0 (0%)

Fundamental Rating

4

Overall BTSG gets a fundamental rating of 4 out of 10. We evaluated BTSG against 102 industry peers in the Health Care Providers & Services industry. While BTSG is still in line with the averages on profitability rating, there are concerns on its financial health. BTSG is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BTSG had positive earnings in the past year.
BTSG had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BTSG reported negative net income in multiple years.
Of the past 5 years BTSG 4 years had a positive operating cash flow.
BTSG Yearly Net Income VS EBIT VS OCF VS FCFBTSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of BTSG (0.98%) is comparable to the rest of the industry.
BTSG has a Return On Equity of 3.39%. This is comparable to the rest of the industry: BTSG outperforms 56.86% of its industry peers.
BTSG has a Return On Invested Capital (4.48%) which is in line with its industry peers.
BTSG had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.62%.
The last Return On Invested Capital (4.48%) for BTSG is above the 3 year average (3.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROIC 4.48%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
BTSG Yearly ROA, ROE, ROICBTSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

The Profit Margin of BTSG (0.49%) is comparable to the rest of the industry.
BTSG's Operating Margin of 2.15% is in line compared to the rest of the industry. BTSG outperforms 49.02% of its industry peers.
In the last couple of years the Operating Margin of BTSG has grown nicely.
Looking at the Gross Margin, with a value of 13.46%, BTSG is doing worse than 68.63% of the companies in the same industry.
BTSG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
BTSG Yearly Profit, Operating, Gross MarginsBTSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

BTSG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BTSG has more shares outstanding
BTSG has more shares outstanding than it did 5 years ago.
BTSG has a better debt/assets ratio than last year.
BTSG Yearly Shares OutstandingBTSG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
BTSG Yearly Total Debt VS Total AssetsBTSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 2.83 indicates that BTSG is not a great score, but indicates only limited risk for bankruptcy at the moment.
BTSG has a Altman-Z score of 2.83. This is in the better half of the industry: BTSG outperforms 64.71% of its industry peers.
BTSG has a debt to FCF ratio of 19.98. This is a negative value and a sign of low solvency as BTSG would need 19.98 years to pay back of all of its debts.
With a Debt to FCF ratio value of 19.98, BTSG perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
BTSG has a Debt/Equity ratio of 1.48. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.48, BTSG is not doing good in the industry: 69.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Altman-Z 2.83
ROIC/WACC0.52
WACC8.54%
BTSG Yearly LT Debt VS Equity VS FCFBTSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.73 indicates that BTSG should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.73, BTSG is doing good in the industry, outperforming 63.73% of the companies in the same industry.
BTSG has a Quick Ratio of 1.37. This is a normal value and indicates that BTSG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.37, BTSG is in line with its industry, outperforming 52.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.37
BTSG Yearly Current Assets VS Current LiabilitesBTSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 122.31% over the past year.
The Revenue has been growing slightly by 1.45% in the past year.
Measured over the past years, BTSG shows a very strong growth in Revenue. The Revenue has been growing by 20.01% on average per year.
EPS 1Y (TTM)122.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%11.7%

3.2 Future

The Earnings Per Share is expected to grow by 29.97% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 7.63% on average over the next years.
EPS Next Y49.38%
EPS Next 2Y33.62%
EPS Next 3Y28.91%
EPS Next 5Y29.97%
Revenue Next Year9.66%
Revenue Next 2Y10.77%
Revenue Next 3Y10.94%
Revenue Next 5Y7.63%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BTSG Yearly Revenue VS EstimatesBTSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
BTSG Yearly EPS VS EstimatesBTSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 34.39, BTSG can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of BTSG is on the same level as its industry peers.
BTSG's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.32.
A Price/Forward Earnings ratio of 21.71 indicates a rather expensive valuation of BTSG.
BTSG's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.13. BTSG is around the same levels.
Industry RankSector Rank
PE 34.39
Fwd PE 21.71
BTSG Price Earnings VS Forward Price EarningsBTSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BTSG is on the same level as its industry peers.
BTSG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 29.14
EV/EBITDA 13.85
BTSG Per share dataBTSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BTSG's earnings are expected to grow with 28.91% in the coming years.
PEG (NY)0.7
PEG (5Y)N/A
EPS Next 2Y33.62%
EPS Next 3Y28.91%

0

5. Dividend

5.1 Amount

No dividends for BTSG!.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTSPRING HEALTH SERVICES

NASDAQ:BTSG (6/16/2025, 4:30:02 PM)

After market: 21.32 0 (0%)

21.32

+0.14 (+0.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners53.2%
Inst Owner Change0.44%
Ins Owners2.93%
Ins Owner Change10.87%
Market Cap3.72B
Analysts84.44
Price Target27.38 (28.42%)
Short Float %14.33%
Short Ratio5.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)47.16%
Min EPS beat(2)-2.7%
Max EPS beat(2)97.01%
EPS beat(4)1
Avg EPS beat(4)3.84%
Min EPS beat(4)-40.94%
Max EPS beat(4)97.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.12%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)2.86%
Revenue beat(4)3
Avg Revenue beat(4)2.37%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)4.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.61%
PT rev (3m)11.21%
EPS NQ rev (1m)-5.45%
EPS NQ rev (3m)30.01%
EPS NY rev (1m)0%
EPS NY rev (3m)25.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.67%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)3.46%
Valuation
Industry RankSector Rank
PE 34.39
Fwd PE 21.71
P/S 0.32
P/FCF 29.14
P/OCF 18.19
P/B 2.2
P/tB N/A
EV/EBITDA 13.85
EPS(TTM)0.62
EY2.91%
EPS(NY)0.98
Fwd EY4.61%
FCF(TTM)0.73
FCFY3.43%
OCF(TTM)1.17
OCFY5.5%
SpS66.39
BVpS9.68
TBVpS-7.18
PEG (NY)0.7
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROCE 5.67%
ROIC 4.48%
ROICexc 4.54%
ROICexgc 14.07%
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
FCFM 1.1%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexcg growth 3Y-9.4%
ROICexcg growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score6
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Debt/EBITDA 5.59
Cap/Depr 38.81%
Cap/Sales 0.66%
Interest Coverage 1.22
Cash Conversion 45.71%
Profit Quality 222.79%
Current Ratio 1.73
Quick Ratio 1.37
Altman-Z 2.83
F-Score6
WACC8.54%
ROIC/WACC0.52
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
EPS Next Y49.38%
EPS Next 2Y33.62%
EPS Next 3Y28.91%
EPS Next 5Y29.97%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%11.7%
Revenue Next Year9.66%
Revenue Next 2Y10.77%
Revenue Next 3Y10.94%
Revenue Next 5Y7.63%
EBIT growth 1Y60.42%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year54.27%
EBIT Next 3Y23.8%
EBIT Next 5YN/A
FCF growth 1Y-141.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.72%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%